|
|
|
|
Fibrogen Inc (NASDAQ: FGEN) |
|
|
|
| |
Fibrogen Inc 's Quick Ratio
FGEN's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth
Current Liabilities decreased faster than Fibrogen Inc 's Cash & cash equivalent, this led to improvement in Fibrogen Inc 's Quick Ratio to 0.46, Quick Ratio remained below Fibrogen Inc average.
Within Major Pharmaceutical Preparations industry 395 other companies have achieved higher Quick Ratio than Fibrogen Inc in first quarter 2025. While Quick Ratio total ranking has improved so far during the Q1 2025 to 2210, from total ranking in the fourth quarter 2024 at 2699.
Explain Quick Ratio?
How much Cash & cash equivalents FGEN´s has?
What are FGEN´s Current Liabilities?
|
Select the Comparisons :
|
|
Select the Ratio:
|
|
| FGEN Quick Ratio |
(Mar 31 2025)
Q1 |
(Dec 31 2024)
Q4 |
(Sep 30 2024)
Q3 |
(Jun 30 2024)
Q2 |
(Mar 31 2024)
Q1 |
| Y / Y Current Liabilities Change |
-62.7 % |
-38.76 % |
-9.02 % |
-23.44 % |
-22.77 % |
| Y / Y Cash & cash equivalent Change |
-81.08 % |
-78.57 % |
-47.88 % |
-58.09 % |
-50.11 % |
| Quick Ratio MRQ |
0.46 |
0.38 |
0.69 |
0.95 |
0.9 |
| FGEN's Total
Ranking |
# 2210 |
# 2699 |
# 2180 |
# 1850 |
# 1927 |
| Seq. Current Liabilities Change |
-44.95 % |
-30.03 % |
28.23 % |
-24.47 % |
-9.62 % |
| Seq. Cash & cash equivalent Change |
-33.42 % |
-61.47 % |
-6.9 % |
-20.77 % |
-24.61 % |
| Quick Ratio first quarter 2025 Company Ranking |
| Within: |
No. |
| Major Pharmaceutical Preparations Industry |
# 396 |
| Healthcare Sector |
# 719 |
| Overall Market |
# 2210 |
| Quick Ratio Statistics |
| High |
Average |
Low |
| 10.66 |
4.02 |
0.38 |
| (Sep 30 2017) |
|
(Dec 31 2024) |
Cumulative Fibrogen Inc 's Quick Ratio
FGEN's Quick Ratio for the trailling 12 Months
FGEN Quick Ratio |
(Mar 31 2025)
12 Months |
(Dec 31 2024)
12 Months |
(Sep 30 2024)
12 Months |
(Jun 30 2024)
12 Months |
(Mar 31 2024)
12 Months |
| Y / Y Current Liabilities TTM Growth |
-33.27 % |
-23.6 % |
-19.13 % |
-20.73 % |
-19.87 % |
| Y / Y Cash & cash equivalent TTM Growth |
-64.43 % |
-57.59 % |
-49.82 % |
-47.1 % |
-38.43 % |
| Quick Ratio TTM |
0.65 |
0.75 |
0.91 |
1.04 |
1.22 |
| Total Ranking TTM |
# 2423
| # 2506
| # 3390
| # 3359
| # 3347
|
| Seq. Current Liabilities TTM Growth |
-18.43 % |
-11.2 % |
-2.44 % |
-5.56 % |
-6.62 % |
| Seq. Cash & cash equivalent TTM Growth |
-28.81 % |
-27.03 % |
-14.94 % |
-19.5 % |
-15.13 % |
On the trailing twelve months basis In spite of the year on year decrease in FGEN's Current Liabilities to $73.39 millions, cumulative Quick Ratio to 0.65 below the FGEN average Quick Ratio. Quick Ratio is the average cumulative value over the last four quarters.
Among companies operating within Major Pharmaceutical Preparations industry 350 other companies have achieved higher Quick Ratio than Fibrogen Inc . While Quick Ratio overall ranking has improved so far to 2423, from total ranking during the twelve months ending fourth quarter 2024 at 2506.
Explain Quick Ratio?
How much Cash & cash equivalents FGEN´s has?
What are FGEN´s Current Liabilities?
| TTM Quick Ratio Company Ranking |
| Within: |
No. |
| Within the Major Pharmaceutical Preparations Industry |
# 351 |
| Healthcare Sector |
# 692 |
| Within the Market |
# 2423 |
| trailing twelve months Quick Ratio Statistics |
| High |
Average |
Low |
| 8.89 |
4.23 |
0.65 |
| (Jun 30 2018) |
|
(Mar 31 2025) |
|
Date modified: 2025-05-15T04:07:47+00:00
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
